Trial Profile
A Phase I Study Of Tirapazamine (NSC 130181) Paclitaxel And Carboplatin With Concurrent Radiation Followed By Tirapazamine/Paclitaxel/Carboplatin Consolidation For Stage III Non-Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Nov 2007
Price :
$35
*
At a glance
- Drugs Tirapazamine (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 31 Oct 2007 Status change from in progress to completed.
- 05 Sep 2006 Status change
- 09 Aug 2005 New trial record.